Known as Zynteglo in Europe where it is approved to treat the rare blood disorder beta-thalassemia, the gene ... in the therapy, used to deliver the genetic material to the body. Cancer is a ...
Dosing can start once again in uniQure's phase 3 trial of its haemophilia B gene therapy, after the FDA concluded that a case of liver cancer seen in the study was unlikely to be caused by the ...